XML 32 R5.htm IDEA: XBRL DOCUMENT v2.4.0.6
Condensed Consolidated Statements of Cash Flows (unaudited) (USD $)
In Thousands, unless otherwise specified
6 Months Ended
Jan. 01, 2012
Dec. 26, 2010
Cash flows from operating activities:    
Net income $ 5,689 $ 11,641
Adjustments to reconcile net income to net cash provided by operating activities:    
Decrease in accrued investment income 1,539 1,479
Depreciation 2,602 3,148
Amortization of intangible assets 1,030 1,031
Change in value / loss on value of UBS option to put securities 0 2,429
Auction rate securities mark to market, trading gain 0 (2,429)
Provision for doubtful accounts receivable, net of reversals (72) 30
Excess and obsolete inventory 474 (100)
Deferred income taxes (30) (569)
Loss on retirement of assets 0 109
Stock-based compensation 3,176 2,485
Unrealized foreign exchange gain (649) (1,157)
Changes in operating assets and liabilities, net    
Accounts receivable (5,263) (4,793)
Inventories (282) (2,294)
Prepaid expenses and other assets 6,172 (4,886)
Accounts payable 828 (2,434)
Accrued compensation and benefits (701) 1,447
Restructuring liabilities (2,449) (1,677)
Accrued warranty 11 (359)
Deferred revenue, net 1,898 2,943
Deferred distributors revenue, net of cost of sales to distributors (2,061) (1,239)
Other accrued liabilities (7,579) 7,397
Other long-term liabilities (379) (2,605)
Net cash provided by operating activities 3,954 9,597
Cash flows used in investing activities:    
Capital expenditures (2,011) (2,407)
Purchases of investments (34,015) (70,147)
Proceeds from maturities of investments and marketable securities 13,889 11,800
Proceeds from sales of investments and marketable securities 18,192 45,481
Net cash used in investing activities (3,945) (15,273)
Cash flows provided by financing activities:    
Proceeds from issuance of common stock 698 273
Net cash provided by financing activities 698 273
Foreign currency effect on cash (1,260) 337
Net decrease in cash and cash equivalents (553) (5,066)
Cash and cash equivalents at beginning of period 49,972 51,944
Cash and cash equivalents at end of period $ 49,419 $ 46,878